Activity

Activity ID

7958

Expires

August 30, 2024

Format Type

Journal-based

CME Credit

1

Fee

$30

CME Provider: JAMA Otolaryngology – Head & Neck Surgery

Description of CME Course

Responding to the coronavirus disease 2019 (COVID-19) pandemic necessitated resource redistribution and disrupted health care access. Several groups offered recommendations to safeguard head and neck oncologic care in this setting. Patients with advanced head and neck cancers were prioritized. In cases of clinical equipoise, nonsurgical treatment modalities were preferred

Disclaimers

1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To identify the key insights or developments described in this article

Keywords

Head and Neck Cancer, Head and Neck Surgery, Laryngology, Oncology, Otolaryngology

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

DOI

10.1001/jamaoto.2021.2019

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.